Question 1

What is the share price of Jagsonpal Pharmaceuticals Ltd today?

Accepted Answer

Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is trading at ₹211.76. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is JAGSNPHARM’s P/E ratio versus the sector?

Accepted Answer

JAGSNPHARM trades at a P/E of 32.0. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is JAGSNPHARM’s dividend yield?

Accepted Answer

JAGSNPHARM has a dividend yield of 1.75%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is JAGSNPHARM’s 52-week high and low?

Accepted Answer

JAGSNPHARM has traded between ₹155 and ₹264.5 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Jagsonpal Pharmaceuticals Ltd?

Accepted Answer

Jagsonpal Pharmaceuticals Ltd has a market capitalisation of ₹1,507 crore.

Question 6

What is JAGSNPHARM’s return on equity?

Accepted Answer

JAGSNPHARM reports a return on equity of 17.3%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.

Question 7

Who are JAGSNPHARM’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is JAGSNPHARM’s promoter holding?

Accepted Answer

Promoters hold 69.06% of JAGSNPHARM. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include JAGSNPHARM?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight JAGSNPHARM carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Jagsonpal Pharmaceuticals Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from JAGSNPHARM’s own numbers. The judgement is yours.

JAGSNPHARM

JAGSNPHARM

Value & Investment Index

VII Detail

Multiples vs Peers

Quality Scores

Versus Its Own History

Scenario analysis

JAGSNPHARM valuation summary

P/E	32.0
ROE	17.3%
ROCE	22.7%
Dividend yield	1.75%